Abstract
INTRODUCTION
A biocompatible material or a biomaterial is any natural or synthetic
substance that incorporates or integrates into a patient' s body. The role of
the biomaterial may be to perform, supplement, or replace a biological
function that is attenuated or lost.
The goal of this report is to assess the current market for biocompatible
materials including medical devices, tissue replacements, and surface coatings.
This report provides a complete overview of recent developments in each major
sector of the biomaterials market. It also outlines the significant medical
applications of each technology; the major market players; recent patents; and
emerging technologies in implantable medical devices, advanced tissue
replacements, and biocompatible surface coatings.
SCOPE OF STUDY
This report contains:
- An examination of the supporting products that have enhanced imaging at
the chemical level (reagents and contrast media) and at the analysis level
(software tools and image management)
- The U.S. markets for medical devices, tissue replacements, and surface
coating biomaterials for a variety of biomaterials categories including
metals, ceramics, polymers, and natural materials
- Assessment of the market for specific medical applications including
orthopedic surgery, cardiovascular surgery and care, wound management,
dentistry, urology, gastrointestinal surgery, ophthalmic care as well as
plastics and reconstructive surgery
- A review of important technology and a discussion of patents in the past
few decades
- Profiles of all the major companies in the industry.
INFORMATION SOURCES
This report has been assembled following an in-depth analysis of primary and
secondary data. Primary research was conducted via telephone interviews with
industry professionals, research scientists, physician-researchers, and
laboratory heads to discover the most recent developments in their fields of
interest. Secondary data was collected via a comprehensive search of the
scientific, peer-reviewed literature, clinical trial reports and databases,
industry trade media, company websites, annual reports, and industry press
releases.
The market assessments provided have been assembled based on publicly
available information from January 2002 up to and including January 2007. The
base year for this report is 2007 and forecast data are provided through 2012.
In many cases, figures for 2006 were not yet released and in these cases
figures were extrapolated from 2006 statistics, first quarter projections for
2007, and historical trends between 2002 and 2007. Market figures are based on
current (2007) dollars and inflation is not computed into the projection
figures.
ANALYST' S CREDENTIALS
Amy Brock, Ph.D. has over 10 years of research experience working at the
interface of the biological sciences, bioengineering, and biophysics. Trained
at the Massachusetts Institute of Technology and Harvard University, she holds
a B.S. and Ph.D. in biomedical science. She is the author of Pharmacogenomics:
New Technologies in the Development of Personalized Therapies, Kinase
Inhibitors and Genetic Diseases and Medical Imaging.
View Cart
